References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN
2008 v2.0, Cancer incidence and mortality world-wide: IARC CancerBase No. 10
[Internet]. Lyon, France: Inter-national Agency for Research on Cancer; 2010.
Available from: http://globocan.iarc.fr [accessed 12/07/2012].
2. United Nations, Population division. World population prospects, the
2010 revision. Available from: http://www.un.org/esa/popula- tion/unpop.htm
[accessed 12/09/2011].
3. Jensen OM, Este`ve J, Møller H, Renard H. Cancer in the European
Community and its member states. Eur J Cancer 1990;26:1167–256.
4. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality
in the European Union: cancer registry data and estimates of national incidence
for 1990. Eur
J Cancer 1997;33:1075–107.
5. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence
and mortality in Europe in 1995. Eur J Cancer 2002;38:99–166.
6.
Boyle P, Ferlay J. Cancer incidence and
mortality in Europe, 2004. Ann Oncol 2005;16(3):481–8.
7. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Cancer
incidence and mortality in Europe, 2006. Ann Oncol 2007;16(3):481–8.
8. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer
incidence and mortality in Europe in 2008. Eur J Cancer 2010;46(4):765–81.
9.
World Health Organization (WHO) Databank.
Geneva, Switzer-land: WHO Statistical Information System. Available from: < http://www.who.int/whosis> [accessed July 2012].
10. Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Comber H,
Bray F. European cancer observatory: cancer incidence, mortality, prevalence
and survival in Europe. Version 1.0 (September 2012) European Network of Cancer
Registries, International Agency for Research on Cancer. Available from: http://eco.iarc.fr [accessed 14/09/2012].
11. World Health Organization. International statistical classification
of diseases and related health problems. Tenth revision, vol. 2. Geneva,
Switzerland: WHO; 1993.
12. Nordpred. A software for predicting trends in cancer incidence.
Available from: http://www.kreftregisteret.no/en/Research/Pro- jects/Nordpred/
[accessed 18/11/2011].
13. Dyba T, Hakulinen T. Comparison of different approaches to incidence
prediction based on simple interpolation techniques. Stat
Med 2000;19(13):1741–52.
14.
Projection de l’incidence et de la mortalite´
par cancer en France en 2011. Rapport technique. Saint-Maurice: Institut de
veille sani-taire; 2011. p. 78. Available from: http://www.invs.sante.fr>.
15. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents: a
technical report. Berlin, Germany: Springer-Verlag (for UICC); 1966.
16. Cancer registry Federation of Bosnia and Herzegovina. Overview of
malignant neoplasms 2009. Institute for Public Health of Federation of Bosnia
and Herzegovina, 2011.
17. Lutz JM, Pury P, Fioretta G, Raymond L. The impact of coding process
on observed cancer mortality trends in Switzerland. Eur J Cancer Prev 2004;13(1):77–81.
18. Pavillon G, Boileau J, Renaud G, et al. Conse´quences des changements
de codage des causes me´dicales de de´ce`s sur les donne´es nationales de
mortalite´ en France, a` partir de l’anne´e 2000. Bull
Epidemiol Hebd 2005;4:13–6.
19. Loos AH, Bray F, McCarron P, Weiderpass E, Hakama M, Parkin DM. Sheep
and goats: separating cervix and corpus uteri from imprecisely coded uterine
cancer deaths, for studies of geographical and temporal variations in
mortality. Eur J Cancer 2004;40:2794–803.
20. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia
R. EUROCARE-4. Survival of cancer patients diag-nosed in 1995–1999. Results and
commentary, the EUROCARE Working Group. Eur J Cancer 2009;45:931–91.
21. Cancer in Ukraine 2009-2010. Bulletin of National Cancer Registry of
Ukraine No. 12. Kiev; 2011. Available from: http://
users.iptelecom.net.ua/~ucr/ [accessed 03-07-2012].
22.
Swiss Federal Statistical Office. Cause of death
statistics FSO – The Statistical Encyclopedia.
23. Engholm G, Ferlay J, Christensen N, et al. NORDCAN: cancer incidence,
mortality, prevalence and survival in the nordic countries, version 5.1 (March 2012).
Association of the Nordic Cancer Registries. Danish Cancer Society. Available
from http:// www.ancr.nu
[accessed 11/06/2012.
24. Ferlay J, Parkin DM, Curado MP, et al. Cancer incidence in five
continents, volumes I to IX: IARC CancerBase No. 9 [Internet]. Lyon, France:
International Agency for Research on Cancer; 2010. Available from: http://ci5.iarc.fr.
25. Curado MP, Edwards B, Shin HR, et al. (Eds.), Cancer incidence in
five continents, vol. IX. IARC Scientific Publications No. 160. Lyon: IARC;
2007.
26. Finnish Cancer Registry. Cancer in Finland 2008 and 2009. Cancer
Society of Finland Publication No. 84, Helsinki; 2011.
27. Registre Morphologique des Tumeurs au Grand – Duche´ de Luxembourg.
Available from: http://www.cancer-registry.lu [accessed 25/06/2012].
28. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E. European
cancer mortality predictions for the year 2012. Ann Oncol 2012;23(4):1044–52, Epub 2012 Feb 28.
29. International Agency for Research on Cancer (IARC). Mono-graphs on
the evaluation of carcinogenic risks to humans, vol 83. Tobacco smoke and
involuntary smoking. Lyon, France: IARC; 2004.
30.
Bray F, Weiderpass E. Lung cancer mortality
trends in 36 European countries: secular trends and birth cohort patterns by
sex and region 1970–2007. Int
J Cancer 2010;126(6):1454–66.
31.
Soerjomataram I, de Vries E, Pukkala E, Coebergh
JW. Excess of cancers in Europe: a study of eleven major cancers amenable to
lifestyle change. Int
J Cancer 2007;120(6):1336–43.
32.
World Cancer Research Fund. Food, nutrition and
the prevention of cancer: a global perspective.
Washington: World Cancer Research Fund/American Institute for
Cancer Research; 1997.
33. Segnan N, Patnick J, von Karsa L, editors. European
guidelines for quality assurance in colorectal
cancer screening and diagnosis. 1st ed. Luxembourg: European Commission, Publications Office of the
European Union; 2010.
34. Soerjomataram I, Pukkala E, Brenner H, Coebergh JW. On the
avoidability of breast cancer in industrialized societies: older mean age at
first birth as an indicator of excess breast cancer risk. Breast Cancer Res Treat 2008;111(2):297–302, Epub 2007 Oct 12.
35. He´ry C, Ferlay J, Boniol M, Autier P. Quantification of changes in
breast cancer incidence and mortality since 1990 in 35 countries with
Caucasian-majority populations. Ann Oncol
2008;19(6):1187–94.
36. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S,
Coebergh JW. Recent trends of cancer in Europe: a combined approach of
incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J
Cancer 2008;44(10):1345–89.
37. Moss SM, Nystro¨m L, Jonsson H, et al. The impact of mammographic
screening on breast cancer mortality in Europe: a review of trend studies. J Med
Screen 2012:19.
38.
Bray F, Lortet-Tieulent J, Ferlay J, Forman D,
Auvinen A. Prostate cancer incidence and mortality trends in 37 European
countries: an overview. Eur
J Cancer 2010;46(17):3040–52.
39. Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation
to diet, physical activity, and body size in blacks, whites, and Asians in the
United States and Canada. J Natl Cancer Inst 1995;87:652–61.
40. Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting
trends in prostate cancer – part II: cause of death misclassification and the
recent rise and fall in prostate cancer mortality. J Natl
Cancer Inst 1999;16:91(12):1025–32.
41. Hakulinen T, Arbyn M, Brewster DH, et al. Harmonization may be
counterproductive – at least for parts of Europe where public health research
operates effectively. Eur J Public Health 2011;21(6):686–7, Epub 2011 Nov
10.
